Novo Nordisk launches weight loss drug Wegovy priced at ₹17,345 per month

Novo Nordisk is banking on its pen-filled device and insulin leadership in India to gain a strong market share despite competitor Eli Lilly’s early mover advantage, and future competition from cheaper generics.

News